ALung Technologies
company
About
ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.
- 501 - 1000
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biotechnology,Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$29.80M
ALung Technologies has raised a total of
$29.80M
in funding over 2 rounds. Their latest funding was raised on
Sep 11, 2013 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 11, 2013 | Series B | $15.80M | 1 | — | — | Detail |
| Oct 11, 2010 | Series A | $14M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ALung Technologies is funded by 1 investors.
MAG Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
MAG Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
